After analyzing the prognosis of these patients, we found that HCC patients with high JunBP /high p-c-Jun (Ser63) expression and high JunBP/high p-c-Jun (Ser73) expression had worse DFS and OS (Fig. 7D, E). This evidence concerns the gene JUN and hepatocellular carcinoma.